东莞凡恩世生物医药有限公司

凡恩世生物医药有限公司
是一家致力于肿瘤和眼病领域新药研发的生物技术公司。公司于2016年成立，研发总部位于美国圣地亚哥，目前在中国上海和东莞设有两个分公司。凡恩世的管理团队成员均为美国海归博士，曾在*的制药和生物技术公司担任资深管理和研发职位，在研发、BD和产品商业化等方面拥有20余年的研发和管理经验。

公司愿景
成为创新治疗主要源泉的领先的生物技术公司
公司使命
寻求创造性的途径，开发创新性的分子，为患者提供强大有效的治疗方案
公司价值观
科学为本，价值创新，正直诚信，质量卓越，合作共赢，铸造成就

Who We Are
Founded in July 2016, Phanes is led by a team of industry veterans with extensive drug discovery and development experience in global pharma and biotech companies, including Pfizer, Amgen, and J&J. Our extensive experience and relentless pursuit of deep science strongly position us to discover and advance robust therapeutic molecules for patients. In addition to a strong pipeline, we have developed disruptive technologies that enable drug discovery.

Technology Platforms
Phanes' two technology platforms are designed to build native IgG-like bispecific antibodies that enhance drug-like properties.
PACbodyTM: Build native IgG-like bispecific antibodies.
ATACCbodyTM: Build bispecific antibodies with modulated activities.